Ketamine Clinics in Baltimore, MD
Browse 9 ketamine therapy providers in Baltimore, Maryland.
Prism Wellness
3600 Clipper Mill Road
Baltimore,
MD
21211
University Of Maryland Advanced Depression Treatment Center
701 W Pratt St
Baltimore,
MD
21201
Omi Psychiatry And Tms
2700 Lighthouse Pt E STE 260
Baltimore,
MD
21224
Charles Wangui
520 Forrest St
Baltimore,
MD
21202
Michelle Blackston
1105 N Point Blvd STE 321
Baltimore,
MD
21224
Natasha Haddad
5601 Loch Raven Blvd
Baltimore,
MD
21239
Johns Hopkins Bayview Community Psychiatry Center
5500 E LOMBARD ST
Baltimore,
MD
21224
Angela Long
1101 N Point Blvd # 1 STE 130-13
Baltimore,
MD
21224
Jh Treat Depression Clinc
600 N WOLFE ST
Baltimore,
MD
21287
Ketamine Treatments in Baltimore
Explore ketamine treatment options available in Baltimore, Maryland.
IV Ketamine Infusion
Off-label psychiatric use. Verify protocols, evidence, risks, and pricing with the provider.
IM Injection
Off-label psychiatric use. Availability and clinical protocols vary by provider.
Spravato (Esketamine)
FDA-approved nasal spray administered in a REMS-certified healthcare setting.
Ketamine-Assisted Psychotherapy
Off-label and still under study. Evidence, training, and protocols vary.
Compare source evidence in Baltimore, Maryland
These 9 directory records are starting points for checking providers. 8 carry an imported Spravato REMS flag and 1 come from ASKP membership data. Neither an NPI entry nor association membership confirms a particular therapy, current intake, price or suitability.
No additional provider-site service check has been recorded for this city cohort. Confirm each listed service directly.
Questions before choosing a service
- Which exact medicine, formulation and route does this location offer? Distinguish Spravato from other ketamine products.
- Who evaluates eligibility, and how can you verify that clinician’s state licence?
- What observation, follow-up and urgent-care arrangements does the provider explain?
- What does the written total include: evaluation, medicine, monitoring, follow-up and any facility fee? Confirm coverage with your insurer.
FDA maintains compounding risk alerts, including its ketamine alerts. Read the current product information and discuss risks and alternatives with your treating clinician. Directory inclusion is not a treatment recommendation or a guarantee of availability.
Directory sources and limits · Spravato information · Questions and treatment distinctions